Transformation of mugwort (Artemisia vulgaris) oil into nanoemulsion as an ethanol-free herbal anesthetic for surgery on koi carp (Cyprinus carpio)     

Raknak  Kantinan  Rattanarom  Panyawut  Praphairaksit  Nalena 《Aquaculture International》2022,30(1):409-418

Fish are frequently anesthetized to reduce stress and injury during various procedures, particularly surgery. Nonetheless, the majority of chemical fish anesthetics have some negative effects on both fish and humans. 2-Phenoxyethanol (2-PE), for example, which is normally used as an anesthetic for ornamental fish, can cause neuropsychological syndromes in humans. To reduce toxicity, some herbal essential oils have been applied as an anesthetic to fish. However, essential oils must be dissolved in ethanol, which has side effects such as disrupting gas exchange in fish. This study aimed to develop mugwort (Artemisia vulgaris) oil as a nanoemulsion without ethanol and determine their optimal concentrations to use as an anesthetic for surgery on koi carp (Cyprinus carpio). Gas chromatography-mass spectrometry (GC/MS) was used to examine the chemical compositions of mugwort oil. The droplet size of mugwort oil nanoemulsion was measured by the dynamic light scattering method. The results revealed that mugwort oil consisted of three major active compounds which were b-pinene (11.7%), 1,8-cineole (10.34%), and a-pinene (8.29%). The average diameter of mugwort oil nanoemulsion droplets was 22.08 ± 0.70 nm. The lowest effective concentrations were 0.6 ml/L for mugwort oil and 12.5 ml/L for mugwort oil nanoemulsion.

  相似文献   

Controlled release of diclofenac from matrix polymer of chitosan and oxidized konjac glucomannan     

Korkiatithaweechai S  Umsarika P  Praphairaksit N  Muangsin N 《Marine drugs》2011,9(9):1649-1663

The controlled release of diclofenac sodium (DFNa) from a chitosan-oxidized konjac glucomannan (CTS-OKG) polymer film was studied. Konjac glucomannan (KGM) was initially oxidized by sodium periodate and then cross-linked to CTS via imine bonds (-C=N-) to form the new CTS-OKG copolymer. The DFNa loaded CTS-OKG polymers were characterized by Fourier transformed infrared spectroscopy (FT-IR) and X-ray diffractometry (XRD). Finally, the release profiles of DFNa from the CTS-OKG polymer matrices were evaluated in a simulated gastrointestinal fluid system comprised of two hours in simulated gastric fluid (SGF; pH 1.2) followed by 24 h in simulated intestinal fluid (SIF; pH 7.4). A 1:2:1 (w/w/w) ratio of CTS:OKG:DFNa prepared at room temperature for 3 hours gave the highest % encapsulation efficiency (EE) of 95.6 ± 0.6 and resulted in a minimal release of DFNa (<1% over 2 h) in SGF (pH 1.2) and a significantly improved sustained release in SIF (pH 7.4) with ~6% and 19% release over 8 and 24 h, respectively), some 15- and five-fold lower than that of the two commercial DFNa preparations, Diclosian and Voltaren. This formulation may be used for further study as a long term intestine controlled release drug model (at least 3 days).  相似文献